Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

WHO Phase III Evaluation of Vectron T500 (Broflanilide 50WP) for IRS in Tanzania

NCT05150808 is registered in ClinicalTrials.gov with London School of Hygiene and Tropical Medicine as lead sponsor.

NCT NCT05150808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05150808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
WHO Phase III Evaluation of Vectron T500 (Broflanilide 50WP) for IRS in Tanzania
Lead sponsor
London School of Hygiene and Tropical Medicine
Phase
Phase 3
Overall status
Unknown status
Start date
October 1, 2020
Completion date
December 31, 2022
Enrollment
12,500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malaria,falciparum